John Segreti to Anti-Infective Agents
This is a "connection" page, showing publications John Segreti has written about Anti-Infective Agents.
Connection Strength
1.101
-
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clin Microbiol Infect. 2005 May; 11 Suppl 3:29-35.
Score: 0.255
-
Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year period. Drugs. 1995; 49 Suppl 2:185-7.
Score: 0.125
-
High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992 Apr; 165(4):667-70.
Score: 0.103
-
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitis. Am J Med. 1991 Dec 30; 91(6A):150S-152S.
Score: 0.101
-
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases. Am J Med. 1991 Dec 30; 91(6A):24S-26S.
Score: 0.101
-
In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens. Antimicrob Agents Chemother. 1990 Jun; 34(6):971-3.
Score: 0.091
-
In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother. 1989 Aug; 33(8):1385-7.
Score: 0.086
-
In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3 Suppl):87S-88S.
Score: 0.084
-
In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis. Antimicrob Agents Chemother. 1989 Jan; 33(1):118-9.
Score: 0.082
-
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother. 1997 Sep; 41(9):1965-72.
Score: 0.038
-
Acute bacterial meningitis. Infect Dis Clin North Am. 1996 Dec; 10(4):797-809.
Score: 0.036